A potent FGFR4-targeted antibody-drug conjugate therapy for patients with rhabdomyosarcoma and other cancers expressing FGFR4

被引：0
|
作者：
Tian, Meijie
Jia, Katrina
Wu, Jerry T.
Wei, Jun S.
Cheuk, Adam T.
Zhang, Zhongmei
Pope, Eleanor G.
Shor, Boris
Tumey, L. Nathan
Khan, Javed
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB042
引用
收藏
页数：3
相关论文
共 50 条
  • [21] CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
    Tian, Meijie
    Wei, Jun S.
    Cheuk, Adam Tai-Chi
    Milewski, David
    Zhang, Zhongmei
    Kim, Yong Yean
    Chou, Hsien-Chao
    Liu, Can
    Badr, Sherif
    Pope, Eleanor G.
    Rahmy, Abdelrahman
    Wu, Jerry T.
    Kelly, Michael C.
    Wen, Xinyu
    Khan, Javed
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [22] A clinical candidate anti-mesothelin-MMAE antibody-drug conjugate (ADC) for therapy of mesothelin-expressing cancers
    Scales, Suzie J.
    Gupta, Nidhi
    Pacheco, Glenn
    Firestein, Ron
    French, Dorothy M.
    Chuh, Josefa
    Zhang, Yin
    Berry, Leanne
    Bostrom, Jenny
    Luis, Elizabeth
    O'Donohue, Aimee Fourie
    Kozak, Katherine R.
    Ross, Sarajane
    Dennis, Mark S.
    Tibbitts, Jay
    Spencer, Susan D.
    CANCER RESEARCH, 2014, 74 (19)
  • [23] NECTIN4 Heterogeneity and Molecular Diversity in Bladder Cancers: Deconstructing the Activity of An Antibody-Drug Conjugate
    Teo, Min Yuen
    Rosenberg, Jonathan E.
    CLINICAL CANCER RESEARCH, 2021, 27 (18) : 4950 - 4952
  • [24] ZW49, a HER2-targeted biparatopic antibody-drug conjugate for the treatment of HER2-expressing cancers
    Hamblett, Kevin J.
    Hammond, Phil W.
    Barnscher, Stuart D.
    Fung, Vincent K.
    Davies, Rupert H.
    Wickman, Grant R.
    Hernandez, Andrea
    Ding, Tong
    Galey, Adam S.
    Winters, Geoffrey C.
    Rich, Jamie R.
    Babcook, John S.
    CANCER RESEARCH, 2018, 78 (13)
  • [25] TAK-164, a GCC-targeted antibody-drug conjugate (ADC) for the treatment of colorectal cancers and other GI malignancies
    Abu-Yousif, Adnan O.
    Bannerman, Bret M.
    Cvet, Donna
    Gallery, Melissa
    Ganno, Michelle L.
    Smith, Michael D.
    Lai, Katharine C.
    Keating, Thomas A.
    Bolleddula, Jayaprakasam
    Stringer, Bradley
    Qian, Mark G.
    Kamali, Afrand
    Eng, Kurt
    Koseoglu, Secil
    Xia, Cindy Q.
    Veiby, O. Petter
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [26] NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease
    Tanaka, Yuka
    Ito, Takamichi
    Murata, Maho
    Tanegashima, Keiko
    Kaku-Ito, Yumiko
    Nakahara, Takeshi
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (03)
  • [27] ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors
    Lopez, Marc
    Crompot, Emerence
    Josselin, Emmanuelle
    Farina, Anne
    Rubis, Marion
    Castellano, Remy
    Fares, Joanna
    Wehbe, Maria
    Collette, Yves
    Charafe, Emmanuelle
    Blanchin, Stephanie
    Romagne, Francois
    Palfi, Aniko
    Hechler, Torsten
    Pahl, Andreas
    Azim Jr, Hatem A.
    Lhospice, Florence
    Mamessier, Emilie
    Bertucci, Francois
    Elands, Jack
    Preville, Xavier
    Olive, Daniel
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (11): : 2998 - 3012
  • [28] Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers
    Si, Yingnan
    Zhang, Ya
    Guan, Jia-Shiung
    Ngo, Hanh Giai
    Totoro, Angela
    Singh, Ajeet Pal
    Chen, Kai
    Xu, Yuanxin
    Yang, Eddy S.
    Zhou, Lufang
    Liu, Runhua
    Liu, Xiaoguang
    VACCINES, 2021, 9 (08)
  • [29] ANTI-MYELOID POLY-PHARMACY COMBINED WITH FGFR4-TARGETED CHIMERIC ANTIGEN RECEPTORS (CARS) EFFECTIVELY TREATS ORTHOTOPIC RHABDOMYOSARCOMA, MODELING CAR EFFECTIVENESS FOR SOLID TUMORS
    Sullivan, Peter
    Kumar, Rajesh
    Li, Wei
    Wang, Lingyang
    Zhang, Yue
    Cheuk, Adam
    Khan, Javed
    Dimitrov, Dimiter
    Orentas, Rimas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A171 - A171
  • [30] Pyridazinediones deliver potent, stable, targeted and efficacious antibody-drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody
    Robinson, Eifion
    Nunes, Joao P. M.
    Vassileva, Vessela
    Maruani, Antoine
    Nogueira, Joao C. F.
    Smith, Mark E. B.
    Pedley, R. Barbara
    Caddick, Stephen
    Baker, James R.
    Chudasama, Vijay
    RSC ADVANCES, 2017, 7 (15) : 9073 - 9077
12345